(Q33992803)

30 July 2017

title

Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma (English)

1 reference

30 July 2017

1 reference

Qi Cao

8

0 references

Bushra Ateeq

Bushra Ateeq

2

0 references

Shanker Kalyana-Sundaram

Shanker Kalyana-Sundaram

3

0 references

Chandan Kumar-Sinha

Chandan Kumar-Sinha

11

0 references

Francesca Demichelis

Francesca Demichelis

Sooryanarayana Varambally

18

0 references

Sooryanarayana Varambally

28

0 references

Nallasivam Palanisamy

Nallasivam Palanisamy

1

0 references

Thomas Giordano

Thomas J Giordano

25

0 references

Mark Rubin

Mark A Rubin

29

0 references

Arul Chinnaiyan

31

Arul M Chinnaiyan

1 reference

30 July 2017

Saravana M Dhanasekaran

12

Saravana M Dhanasekaran

1 reference

30 July 2017

30

Christopher A Maher

1 reference

30 July 2017

14

Raquel Esgueva

1 reference

30 July 2017

4

Dorothee Pflueger

1 reference

30 July 2017

27

Scott A Tomlins

1 reference

30 July 2017

9

Xuhong Cao

1 reference

30 July 2017

16

Christopher J LaFargue

1 reference

30 July 2017

21

Rainer Kuefer

1 reference

30 July 2017

20

Tarek A Bismar

1 reference

30 July 2017

6

Sunita Shankar

1 reference

30 July 2017

5

Kalpana Ramnarayanan

1 reference

30 July 2017

22

Douglas R Fullen

1 reference

30 July 2017

Bo Han

7

1 reference

30 July 2017

Khalid Suleman

10

1 reference

30 July 2017

Ying-bei Chen

13

1 reference

30 July 2017

Samprit Banerjee

15

1 reference

30 July 2017

Javed Siddiqui

17

1 reference

30 July 2017

Peter Moeller

19

1 reference

30 July 2017

Timothy M Johnson

23

1 reference

30 July 2017

Joel K Greenson

24

1 reference

30 July 2017

Patrick Tan

26

1 reference

30 July 2017

language of work or name

English

0 references

publication date

6 June 2010

1 reference

30 July 2017

1 reference

30 July 2017

volume

16

1 reference

30 July 2017

issue

7

1 reference

30 July 2017

page(s)

793-798

1 reference

Profiling critical cancer gene mutations in clinical tumor samples

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Chimeric transcript discovery by paired-end transcriptome sequencing

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

(V600E)BRAF is associated with disabled feedback inhibition of RAF-MEK signaling and elevated transcriptional output of the pathway

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Transcriptome sequencing to detect gene fusions in cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

BRAF activation initiates but does not maintain invasive prostate adenocarcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Repression of E-cadherin by the polycomb group protein EZH2 in cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

A fluorescence in situ hybridization screen for E26 transformation-specific aberrations: identification of DDX5-ETV4 fusion protein in prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Recurrent gene fusions in prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

BRAF silencing by short hairpin RNA or chemical blockade by PLX4032 leads to different responses in melanoma and thyroid carcinoma cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Characterization of TMPRSS2:ETV5 and SLC45A3:ETV5 gene fusions in prostate cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

BRAF and KRAS mutations in prostatic adenocarcinoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

BRAF mutation in thyroid cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Oncogenic AKAP9-BRAF fusion is a novel mechanism of MAPK pathway activation in thyroid cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Regulation of Her2/neu promoter activity by the ETS transcription factor, ER81.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Mutations of the BRAF gene in human cancer

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Analysis of the ERK-stimulated ETS transcription factor ER81.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Inhibition of H-ras oncogene transformation of NIH3T3 cells by protease inhibitors.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

In vivo antitumor activity of MEK and phosphatidylinositol 3-kinase inhibitors in basal-like breast cancer models.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

BRAF mutations in colon cancer are not likely attributable to defective DNA mismatch repair

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903732

BRAF Mutation in Papillary Thyroid Carcinoma

29 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20526349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chromosomal translocations as a mechanism of BRAF activation in two cases of large congenital melanocytic nevi

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/20526349

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

An integrative approach to reveal driver gene fusions from paired-end sequencing data in cancer

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM.2166

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/NM.2166

1 reference

30 July 2017

1 reference

30 July 2017

1 reference